// App-Quantinova.ai

330 : Circulating tumor cells (CTC) as potential biomarkers in neoadjuvant chemotherapy of muscle invasive bladder cancer (MIBC).

Researchers

Presenter

  • Ajjai Shivaram Alva

Principal Investigators

  • Stephanie Daignault-Newton

  • Cristian Ionescu

  • Mike Schwartz

  • Tamara Huebner

  • Melanie Clark

  • Maha Hussain

Medical Centers

  • Division of Biostatistics, University of Michigan Medical School, Ann Arbor, MI

  • Fluxion Biosciences, San Francisco, CAUniversity of Michigan, Ann Arbor, MIUniversity of Michigan, Ann Arbor, MI

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved